Q2 FY2023 · Quarterly report
August 4, 2023 · 69 pages
Read Ovid Therapeutics Inc.'s results firsthand
Preview the first 2 pages of this quarterly report
Create a free account to start reading
Full documents are included with Professional
Ovid Therapeutics Inc.
2.74
USD
+0.34
(+14.17%)
